 |
|
Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
Amira Ismail Mostafa, Ayman Elsayed Salem, Heba Allah Moussa Ahmed, Aml Ibrahim Bayoumi, Radwa M. Abdel Halim, Rasha M. Abdel Samie
Tuberc Respir Dis. 2021;84(3):200-208. Published online 2021 Apr 6 DOI: https://doi.org/10.4046/trd.2020.0122
|
|
Citations to this article as recorded by
 Japanese clinical practice guide 2022 for hypersensitivity pneumonitis
Hiromi Tomioka, Yasunari Miyazaki, Yoshikazu Inoue, Ryoko Egashira, Tetsuji Kawamura, Hiroyuki Sano, Takeshi Johkoh, Tamiko Takemura, Takeshi Hisada, Junya Fukuoka
Respiratory Investigation.2024; 62(1): 16. CrossRef Krebs von den Lungen-6 (KL-6) as a diagnostic marker for pulmonary fibrosis: A systematic review and meta-analysis
Chuanzhu Wang, Qingbao Wang, Tong Liu, Jun Zhu, Boke Zhang
Clinical Biochemistry.2023; 114: 30. CrossRef A case of development of autoimmune pulmonary alveolar proteinosis during the treatment of hypersensitivity pneumonitis
Maki Asami-Noyama, Kosuke Ito, Misa Harada, Yukari Hisamoto, Yoshie Kunihiro, Eiji Ikeda, Tasuku Yamamoto, Junki Suizu, Ayumi Fukatsu, Syuichiro Ohata, Yoriyuki Murata, Keiji Oishi, Yoshikazu Yamaji, Nobutaka Edakuni, Tomoyuki Kakugawa, Tsunahiko Hirano,
Respiratory Medicine Case Reports.2023; 44: 101862. CrossRef Biomarkers of Progressive Fibrosing Interstitial Lung Diseases
E. V. Bolotova, Yu. G. Yurkova
Innovative Medicine of Kuban.2023; (4): 126. CrossRef Current perspective of progressive-fibrosing interstitial lung disease
Tomoo Kishaba
Respiratory Investigation.2022; 60(4): 503. CrossRef Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis
Jie He, Jiangliu Zhang, Xinyi Ren
Frontiers in Immunology.2022;[Epub] CrossRef
|